These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29386497)

  • 21. Acute inflammatory demyelinating polyradiculoneuropathy in a patient receiving oxaliplatin-based chemotherapy.
    Yoon JY; Nam TS; Kim MK; Hwang JE; Shim HJ; Cho SH; Chung IJ; Bae WK
    Asia Pac J Clin Oncol; 2012 Jun; 8(2):201-4. PubMed ID: 22524580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Shao YY; Hong RL
    Anticancer Res; 2008; 28(5B):3115-7. PubMed ID: 19031966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-fluorouracil-induced leukoencephalopathy with acute stroke-like presentation fulfilling criteria for recombinant tissue plasminogen activator therapy.
    Kinno R; Kii Y; Uchiyama M; Owan Y; Yamazaki T; Fukui T
    J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):387-9. PubMed ID: 23422344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxaliplatin plus hydroxycamptothecine versus oxaliplatin plus 5-fluorouracil and leucovorin in treatment of advanced colorectal cancer.
    Yao Y; Sun YJ; Zhao H; Guo YW; Lin F; Cai X; Tang XC; Tang LN; Zhang W
    Chin Med J (Engl); 2006 Nov; 119(21):1829-33. PubMed ID: 17097039
    [No Abstract]   [Full Text] [Related]  

  • 25. Neoadjuvant treatment with weekly high-dose 5-fluorouracil as a 24h-infusion, folinic acid and biweekly oxaliplatin in patients with primary resectable liver metastases of colorectal cancer: long-term results of a phase II trial.
    Boxberger F; Albrecht H; Konturek PC; Reulbach U; Maennlein G; Meyer T; Hohenberger W; Hahn EG; Wein A
    Med Sci Monit; 2010 Feb; 16(2):CR49-55. PubMed ID: 20110914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New approaches to breast cancer: oxaliplatin combined with 5-fluorouracil and folinic acid in pretreated advanced breast cancer patients: preliminary reports.
    Leonardi V; Savio G; Laudani A; Blasi L; Agostara B
    Ann N Y Acad Sci; 2002 Jun; 963():91-7. PubMed ID: 12095933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediastinal extravasation of oxaliplatin.
    Pijaume CP; Saigí E
    Clin Adv Hematol Oncol; 2012 Aug; 10(8):548-9. PubMed ID: 23073057
    [No Abstract]   [Full Text] [Related]  

  • 28. Phase II study of weekly oxaliplatin and high-dose infusional 5-fluorouracil plus leucovorin in pretreated patients with metastatic colorectal cancer.
    Chiara S; Nobile MT; Gozza A; Taveggia P; Heouaine A; Pastrone I; Percivale PL; Lionetto R; Sanguineti O; Rosso R
    Anticancer Res; 2004; 24(1):355-60. PubMed ID: 15015621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxaliplatin with weekly bolus 5-fluorouracil and leucovorin in pretreated advanced colorectal cancer patients: a phase II study.
    Yang TS; Chen JS; Tang R; Chiang JM; Hsieh PS; Yeh CY; Changchien CR
    Chemotherapy; 2003 Jul; 49(4):194-9. PubMed ID: 12886055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [FOLFOX].
    Mishima H; Ikenaga M; Tsujinaka T; Yasui M; Kashiwazaki M; Miyazaki M; Hirao M; Fujitani K; Nakamori S
    Gan To Kagaku Ryoho; 2006 Jul; 33(7):911-4. PubMed ID: 16835479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weekly oxaliplatin, high-dose infusional 5-fluorouracil and folinic acid as palliative third-line therapy of advanced colorectal carcinoma.
    Kallen KJ; Hofmann MA; Timm A; Gödderz W; Galle PR; Heike M
    Z Gastroenterol; 2000 Feb; 38(2):153-7. PubMed ID: 10721170
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Organizing pneumonia with fatal outcome after adjuvant chemotherapy with FOLFOX.
    Vargas A; Montironi C; Buxó E
    Arch Bronconeumol; 2015 Nov; 51(11):610. PubMed ID: 26163115
    [No Abstract]   [Full Text] [Related]  

  • 33. Gefitinib in combination with 5-fluorouracil (5-FU)/folinic acid and irinotecan in patients with 5-FU/oxaliplatin- refractory colorectal cancer: a phase I/II study of the Arbeitsgemeinschaft für Internistische Onkologie (AIO).
    Hofheinz RD; Kubicka S; Wollert J; Arnold D; Hochhaus A
    Onkologie; 2006 Dec; 29(12):563-7. PubMed ID: 17202826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.
    Pectasides D; Pectasides M; Farmakis D; Gaglia A; Koumarianou A; Nikolaou M; Koumpou M; Kountourakis P; Papaxoinis G; Mitrou P; Economopoulos T; Raptis SA
    Gynecol Oncol; 2004 Oct; 95(1):165-72. PubMed ID: 15385127
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An association between transient hypokalemia and severe acute oxaliplatin-related toxicity predominantly in women.
    Chay WY; Chew L; Yeoh TT; Tan MH
    Acta Oncol; 2010 May; 49(4):515-7. PubMed ID: 20092386
    [No Abstract]   [Full Text] [Related]  

  • 36. Phase I clinical trial of lenalidomide in combination with 5-fluorouracil, leucovorin, and oxaliplatin in patients with advanced cancer.
    Said R; Ye Y; Hong DS; Naing A; Falchook G; Fu S; Wheler JJ; Piha-Paul S; Tsimberidou AM
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):575-81. PubMed ID: 26825327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of oxaliplatin in combination with leucovorin and fluorouracil as first-line chemotherapy in patients with metastatic squamous cell carcinoma of esophagus.
    Wang J; Chang J; Yu H; Wu X; Wang H; Li W; Ji D; Peng W
    Cancer Chemother Pharmacol; 2013 Apr; 71(4):905-11. PubMed ID: 23370661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.
    Kalofonos HP; Papakostas P; Makatsoris T; Papamichael D; Vourli G; Xanthakis I; Aravantinos G; Papadimitriou C; Pentheroudakis G; Varthalitis I; Samelis G; Syrigos KN; Xiros N; Stavropoulos M; Kosmidis P; Christodoulou C; Linardou H; Skondra M; Pectasides D; Economopoulos T; Fountzilas G
    Anticancer Res; 2010 Oct; 30(10):4325-33. PubMed ID: 21036759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer.
    Goldberg RM; Tabah-Fisch I; Bleiberg H; de Gramont A; Tournigand C; Andre T; Rothenberg ML; Green E; Sargent DJ
    J Clin Oncol; 2006 Sep; 24(25):4085-91. PubMed ID: 16943526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase I/II study of irinotecan when added to 5-fluorouracil and leucovorin and pelvic radiation in locally advanced rectal cancer: a Colorectal Clinical Oncology Group Study.
    Glynne-Jones R; Falk S; Maughan TS; Meadows HM; Sebag-Montefiore D
    Br J Cancer; 2007 Feb; 96(4):551-8. PubMed ID: 17262086
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.